US Physicalrapy Net Income
| USPH Stock | USD 88.14 2.73 3.20% |
As of the 11th of February 2026, US Physicalrapy owns the Risk Adjusted Performance of 0.1554, downside deviation of 1.82, and Mean Deviation of 1.49. Concerning fundamental indicators, the technical analysis model makes it possible for you to check potential technical drivers of US Physicalrapy, as well as the relationship between them.
US Physicalrapy's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing US Physicalrapy's valuation are provided below:US Physicalrapy does not at this time have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Is there potential for Health Care Providers & Services market expansion? Will USPH introduce new products? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, US Physicalrapy's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
US Physicalrapy 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to US Physicalrapy's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of US Physicalrapy.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in US Physicalrapy on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding US Physicalrapy or generate 0.0% return on investment in US Physicalrapy over 90 days. US Physicalrapy is related to or competes with Healthcare Services, Select Medical, CONMED, Adapthealth Corp, Pennant, Goodrx Holdings, and Zenas BioPharma. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post... More
US Physicalrapy Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure US Physicalrapy's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess US Physicalrapy upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.82 | |||
| Information Ratio | 0.1372 | |||
| Maximum Drawdown | 10.34 | |||
| Value At Risk | (3.21) | |||
| Potential Upside | 3.72 |
US Physicalrapy Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for US Physicalrapy's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as US Physicalrapy's standard deviation. In reality, there are many statistical measures that can use US Physicalrapy historical prices to predict the future US Physicalrapy's volatility.| Risk Adjusted Performance | 0.1554 | |||
| Jensen Alpha | 0.2535 | |||
| Total Risk Alpha | 0.1325 | |||
| Sortino Ratio | 0.1518 | |||
| Treynor Ratio | 0.2962 |
US Physicalrapy February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1554 | |||
| Market Risk Adjusted Performance | 0.3062 | |||
| Mean Deviation | 1.49 | |||
| Semi Deviation | 1.48 | |||
| Downside Deviation | 1.82 | |||
| Coefficient Of Variation | 530.64 | |||
| Standard Deviation | 2.02 | |||
| Variance | 4.07 | |||
| Information Ratio | 0.1372 | |||
| Jensen Alpha | 0.2535 | |||
| Total Risk Alpha | 0.1325 | |||
| Sortino Ratio | 0.1518 | |||
| Treynor Ratio | 0.2962 | |||
| Maximum Drawdown | 10.34 | |||
| Value At Risk | (3.21) | |||
| Potential Upside | 3.72 | |||
| Downside Variance | 3.33 | |||
| Semi Variance | 2.19 | |||
| Expected Short fall | (1.70) | |||
| Skewness | 0.4289 | |||
| Kurtosis | 0.9829 |
US Physicalrapy Backtested Returns
US Physicalrapy appears to be very steady, given 3 months investment horizon. US Physicalrapy retains Efficiency (Sharpe Ratio) of 0.19, which indicates the firm had a 0.19 % return per unit of price deviation over the last 3 months. We have found twenty-eight technical indicators for US Physicalrapy, which you can use to evaluate the volatility of the company. Please review US Physicalrapy's Downside Deviation of 1.82, mean deviation of 1.49, and Risk Adjusted Performance of 0.1554 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, US Physicalrapy holds a performance score of 14. The entity owns a Beta (Systematic Risk) of 1.25, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, US Physicalrapy will likely underperform. Please check US Physicalrapy's coefficient of variation, semi variance, period momentum indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether US Physicalrapy's current price history will revert.
Auto-correlation | 0.44 |
Average predictability
US Physicalrapy has average predictability. Overlapping area represents the amount of predictability between US Physicalrapy time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of US Physicalrapy price movement. The serial correlation of 0.44 indicates that just about 44.0% of current US Physicalrapy price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 6.11 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, US Physicalrapy reported net income of 45.6 M. This is 86.64% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 92.01% higher than that of the company.
USPH Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses US Physicalrapy's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of US Physicalrapy could also be used in its relative valuation, which is a method of valuing US Physicalrapy by comparing valuation metrics of similar companies.US Physicalrapy is currently under evaluation in net income category among its peers.
USPH Fundamentals
| Return On Equity | 0.0844 | ||||
| Return On Asset | 0.0426 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 1.56 B | ||||
| Shares Outstanding | 15.2 M | ||||
| Shares Owned By Insiders | 1.94 % | ||||
| Shares Owned By Institutions | 98.06 % | ||||
| Number Of Shares Shorted | 908.09 K | ||||
| Price To Earning | 34.35 X | ||||
| Price To Book | 2.55 X | ||||
| Price To Sales | 1.73 X | ||||
| Revenue | 671.35 M | ||||
| Gross Profit | 164.91 M | ||||
| EBITDA | 86.91 M | ||||
| Net Income | 45.6 M | ||||
| Cash And Equivalents | 48.57 M | ||||
| Cash Per Share | 3.73 X | ||||
| Total Debt | 295.23 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 1.43 X | ||||
| Book Value Per Share | 33.12 X | ||||
| Cash Flow From Operations | 74.94 M | ||||
| Short Ratio | 4.57 X | ||||
| Earnings Per Share | 2.40 X | ||||
| Price To Earnings To Growth | 3.05 X | ||||
| Target Price | 105.33 | ||||
| Number Of Employees | 4.03 K | ||||
| Beta | 1.3 | ||||
| Market Capitalization | 1.3 B | ||||
| Total Asset | 1.17 B | ||||
| Retained Earnings | 227.26 M | ||||
| Working Capital | 21.3 M | ||||
| Current Asset | 60.18 M | ||||
| Current Liabilities | 19.01 M | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.01 % | ||||
| Net Asset | 1.17 B | ||||
| Last Dividend Paid | 1.79 |
About US Physicalrapy Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze US Physicalrapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of US Physicalrapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of US Physicalrapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is there potential for Health Care Providers & Services market expansion? Will USPH introduce new products? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, US Physicalrapy's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.